Alexander Zürcher
Fortuna: 90 706 $ al 31/05/2026
Fortuna: 90 706 $ al 31/05/2026
Mr. Alexander Zürcher is a Chief Operating Officer at Molecular Partners AG.
Mr. Zürcher was previously employed as a Director-Drug Product Development by Cytos Biotechnology AG and a Head-Research & Development Operations by Spirig Pharma AG.
He received his graduate degree from the University of Basel.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MOLECULAR PARTNERS AG 0,06 % | 31/12/2025 | 22.571 ( 0,06 % ) | 90 706 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MOLECULAR PARTNERS AG | Director de Operaciones | 01/07/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Spirig Pharma AG
Spirig Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Director Técnico/Científico/I+D | - |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Commercial Services |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Spirig Pharma AG
Spirig Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.